These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23332110)

  • 1. [Angiotensin-2 type 1 receptors (AT1R) and cancers].
    Dolley-Hitze T; Verhoest G; Jouan F; Le Pogamp P; Arlot-Bonnemains Y; Oger E; Belaud-Rotureau MA; Rioux-Leclercq N; Vigneau C
    Nephrol Ther; 2013 Apr; 9(2):85-91. PubMed ID: 23332110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin inhibition and malignancies: a review.
    Rosenthal T; Gavras I
    J Hum Hypertens; 2009 Oct; 23(10):623-35. PubMed ID: 19339998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M; Wuerzner G
    Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On target to dual block RAS?
    Papadopoulos DP; Papademetriou V; Makris TK
    Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
    Etminan M; Zhang B; Fitzgerald M; Brophy JM
    Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer and renin-angiotensin system].
    Uemura H; Kubota Y
    Nihon Rinsho; 2012 Sep; 70(9):1530-5. PubMed ID: 23012799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
    Fomin VV; Moiseev SV; Mukhin NA
    Ter Arkh; 2007; 79(10):86-91. PubMed ID: 18154154
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
    Pauly DF
    Heart Fail Clin; 2010 Jan; 6(1):25-6. PubMed ID: 19945057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can drugs influencing the renin-angiotensin system prevent diabetes mellitus? A lesson from randomized clinical trials.
    Filipiak KJ
    Cardiol J; 2010; 17(5):435-6. PubMed ID: 20865671
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin inhibition: what are the clinical perspectives?
    Hollenberg NK
    Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renin-angiotensin system modulation: instructions for use].
    Bellis A; Rozza F; Crispo S; Trimarco B
    G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.